WO2007109288A3 - Enantiomerically pure r-etifoxine, pharmaceutical compositions thereof and methods of their use - Google Patents
Enantiomerically pure r-etifoxine, pharmaceutical compositions thereof and methods of their use Download PDFInfo
- Publication number
- WO2007109288A3 WO2007109288A3 PCT/US2007/006958 US2007006958W WO2007109288A3 WO 2007109288 A3 WO2007109288 A3 WO 2007109288A3 US 2007006958 W US2007006958 W US 2007006958W WO 2007109288 A3 WO2007109288 A3 WO 2007109288A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pharmaceutical compositions
- etifoxine
- methods
- enantiomerically pure
- compounds
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 229960003817 etifoxine Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- IBYCYJFUEJQSMK-QGZVFWFLSA-N (4r)-6-chloro-n-ethyl-4-methyl-4-phenyl-3,1-benzoxazin-2-amine Chemical compound C1([C@]2(C)C3=CC(Cl)=CC=C3N=C(O2)NCC)=CC=CC=C1 IBYCYJFUEJQSMK-QGZVFWFLSA-N 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Enantiomerically pure R-etifoxine and pharmaceutically acceptable salts, solvates, hydrates or prodrugs thereof are provided. Also provided are pharmaceutical compositions comprising the compounds and methods of treating disorders associated with central nervous system using the compounds and pharmaceutical compositions.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78451406P | 2006-03-20 | 2006-03-20 | |
US60/784,514 | 2006-03-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007109288A2 WO2007109288A2 (en) | 2007-09-27 |
WO2007109288A3 true WO2007109288A3 (en) | 2008-04-03 |
Family
ID=38372325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/006958 WO2007109288A2 (en) | 2006-03-20 | 2007-03-20 | Enantiomerically pure r-etifoxine, pharmaceutical compositions thereof and methods of their use |
Country Status (2)
Country | Link |
---|---|
US (1) | US20080039453A1 (en) |
WO (1) | WO2007109288A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2930891B1 (en) * | 2008-05-06 | 2010-09-24 | Biocodex | ANTI-AMNESIAN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME |
FR2937552B1 (en) * | 2008-10-27 | 2011-05-06 | Biocodex | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF ALCOHOLIC WEANING SYNDROME |
WO2014181280A1 (en) * | 2013-05-08 | 2014-11-13 | Genovo Development Services Limited | Stable compositions of etifoxine and its salts |
FR3016881B1 (en) * | 2014-01-29 | 2016-03-04 | Biocodex | TREATMENT OF DEGENERESCENCES AND PHOTO-INDUCED LESIONS OF THE RETINA |
EP3151820A4 (en) | 2014-06-06 | 2017-11-22 | Flexus Biosciences, Inc. | Immunoregulatory agents |
US11242319B2 (en) | 2014-11-05 | 2022-02-08 | Flexus Biosciences, Inc. | Immunoregulatory agents |
UY36390A (en) | 2014-11-05 | 2016-06-01 | Flexus Biosciences Inc | MODULATING COMPOUNDS OF INDOLAMINE ENZYME 2,3-DIOXYGENASE (IDO), ITS SYNTHESIS METHODS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
AR102537A1 (en) | 2014-11-05 | 2017-03-08 | Flexus Biosciences Inc | IMMUNOMODULATING AGENTS |
PT3347006T (en) * | 2015-03-20 | 2022-10-17 | Gaba Therapeutics Inc | Deuterated analogs of etifoxine, their derivatives and uses therof |
US10420773B2 (en) | 2017-09-26 | 2019-09-24 | Ovid Therapeutics Inc. | Methods of treating developmental disorders and/or seizure disorders with etifoxine |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3725404A (en) * | 1966-11-24 | 1973-04-03 | Hoechst Ag | 2-amino-4,4-di-substituted-4h-3,1-benzoxazines |
DE3439055A1 (en) * | 1984-10-25 | 1986-04-30 | Hoechst Ag, 6230 Frankfurt | Substituted 4H-3,1-benzoxazines and a medicament containing a benzodiazepine derivative |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001052823A2 (en) * | 2000-01-20 | 2001-07-26 | Noven Pharmaceuticals, Inc. | Compositions to effect the release profile in the transdermal administration of drugs |
FR2888749B1 (en) * | 2005-07-19 | 2007-10-12 | Biocodex | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CEREBRAL EDEMA |
FR2888748B1 (en) * | 2005-07-19 | 2007-10-12 | Biocodex | NEUROPROTECTIVE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME |
-
2007
- 2007-03-20 WO PCT/US2007/006958 patent/WO2007109288A2/en active Application Filing
- 2007-03-20 US US11/726,286 patent/US20080039453A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3725404A (en) * | 1966-11-24 | 1973-04-03 | Hoechst Ag | 2-amino-4,4-di-substituted-4h-3,1-benzoxazines |
DE3439055A1 (en) * | 1984-10-25 | 1986-04-30 | Hoechst Ag, 6230 Frankfurt | Substituted 4H-3,1-benzoxazines and a medicament containing a benzodiazepine derivative |
Also Published As
Publication number | Publication date |
---|---|
WO2007109288A2 (en) | 2007-09-27 |
US20080039453A1 (en) | 2008-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007109288A3 (en) | Enantiomerically pure r-etifoxine, pharmaceutical compositions thereof and methods of their use | |
WO2007027527A3 (en) | Isoindole-imide compounds and compositions comprising and methods of using the same | |
MX2009003038A (en) | 5-substituted quinazolinone derivatives and compositions comprising and methods of using the same. | |
TWI369987B (en) | New pharmaceutical compositions for the treatment of hyper-proliferative disorders | |
GEP20146082B (en) | Compositions and methods of wnt signaling modulators | |
UA95975C2 (en) | N-methylaminomethyl isoindole compounds, compositions comprising thereof and methods of using the same | |
PL2019683T3 (en) | Administration of growth factors for the treatment of cns disorders | |
WO2007109120A3 (en) | Imidazolothiazole compounds for the treatment of disease | |
WO2009017837A3 (en) | Sublingual fentanyl spray | |
WO2009042114A3 (en) | Phenazine derivatives and uses thereof | |
WO2007112014A3 (en) | New therapeutic combinations for the treatment of depression | |
SI2176252T1 (en) | 2, 3-dihydrobenzoš1, 4ćdioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous systeme diseases | |
MY145795A (en) | Pyrazoline compounds | |
WO2008144720A3 (en) | Inhibitors of igf-1r signaling for the treatment of respiratory disorders | |
WO2009071690A3 (en) | 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases | |
WO2008097924A3 (en) | Pharmaceutical compositions comprising dextromethorphan analogs for the treatment of neurological disorders | |
WO2006116221A3 (en) | Therapeutic combinations for the treatment or prevention of psychotic disorders | |
WO2007136741A3 (en) | N-desmethyl-doxepin and methods of using the same to treat sleep disorders | |
WO2009085270A3 (en) | Use of inhibitors of c0nnexin43 for treatment of fibrotic conditions | |
WO2009071689A3 (en) | 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases | |
WO2008052139A3 (en) | Ultra low dose doxepin and methods of using the same to treat sleep disorders | |
WO2008020306A3 (en) | Isoindole derivatives | |
WO2007146335A3 (en) | Compounds and compositions for treatment of cancer | |
UA97401C2 (en) | Improved taste-masking extrudates | |
MX2010001243A (en) | Anti-inflammatory composition. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07753575 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07753575 Country of ref document: EP Kind code of ref document: A2 |